Duspacol 50 indications
Irritable bowel syndrome & allied conditions eg, chronic irritable colon, spastic constipation, mucous colitis and spastic colitis. Symptomatic treatment of abdominal pain, cramps, nonspecific diarrhoea & flatulence. GI spasm secondary to organic diseases eg, diverticulitis, gastritis, duodenitis, oesophagitis, cholecystitis, Crohn's disease, ulcerative colitis, peptic ulcer, gallbladder disease, hiatus hernia, GIT inflammation.
Uses of Duspacol 50 in details
Duspacol 50 is used to treat irritable bowel syndrome (disorder of the intestines that leads to cramps in the abdomen, gas, bloating and changes in bowel habits). It is also used to treat other conditions that involve spasm and pain related to small and large bowel.
Duspacol 50 description
Each capsule contains mebeverine 200 mg.
Duspacol 50 also contains the following excipients: Capsule Content (Granules): Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose, methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30% and glycerol triacetate. Capsule Shell: Gelatin, titanium dioxide (E171). Printing Ink: Shellac (E904), black iron oxide (E172), propylene glycol, concentrated ammonia solution, potassium hydroxide.
Duspacol 50 dosage
Adults: 1 capsule twice daily (1 in the morning and 1 in the evening).
Special Populations: Elderly, Renal and Hepatic Impairment: No posology studies in elderly, renal and/or hepatically impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatically impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.
Missed Dose: In case of ≥1 doses missed, continue with the next dose as prescribed; the missed doses are not to be taken in addition to the regular dose.
Administration: The capsules should be swallowed with a sufficient amount of water (at least 100 mL of water).
It should not be chewed because the coating is intended to ensure a prolonged release mechanism.
Duspacol 50 interactions
No interaction studies have been performed except with alcohol. In vitro and in vivo studies in animals have demonstrated the absence of any interaction between Duspacol 50 and ethanol.
Incompatibilities: Not applicable.
Duspacol 50 side effects
Although adverse effects appear rare, gastrointestinal disturbances, dizziness, headache, insomnia, anorexia and tachycardia have been reported in patients receiving Duspacol 50.
Duspacol 50 contraindications
Hypersensitivity to Duspacol 50 or to any of the excipients of Duspacol 50.
Active ingredient matches for Duspacol 50:
List of Duspacol 50 substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Duspacol 200 | |
| Duspalina 100 | |
| Duspalina 135 | |
| Duspalina 200 | |
| Duspamen (Bahrain, Oman) | |
| Duspaphen 135 | |
| Dusparaz 135 | |
| Dusparaz 200 | |
| Dusparaz 50 | |
| Duspatal (Chile, Germany, Italy, Netherlands, Portugal) | |
| Capsule; Oral; Mebeverine Hydrochloride 200 mg (Grunenthal) | |
| Dragee; Oral; Mebeverine Hydrochloride 135 mg (Grunenthal) | |
| Tablet, Film-Coated; Oral; Mebeverine Hydrochloride 100 mg (Grunenthal) | |
| Duspatal Retard (Chile, Portugal) | |
| Capsule, Retard; Oral; Mebeverine Hydrochloride 200 mg | |
| Duspatalin (Argentina, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Colombia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, Indonesia, Latvia, Lithuania, Luxembourg, Malaysia, Mexico, Myanmar, Oman, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, Slovakia, Spain, Sri Lanka, Switzerland, Taiwan, Tunisia, Turkey, Venezuela) | |
| Capsule, Prolonged Release; Oral; Mebeverine Hydrochloride 200 mg (Abbott Products) | |
| Tablet, Film-Coated; Oral; Mebeverine Hydrochloride 100 mg (Abbott Products) | |
| Duspatalin 200mg - 30 Capsule (Abbott Products) | $ 26.00 |
| Duspatalin 135 mg x 1's (Abbott Products) | |
| Duspatalin 135 mg x 5 Blister x 10 Tablet (Abbott Products) | |
| Duspatalin 135 mg x 50's (Abbott Products) | $ 10.20 |
| Duspatalin 200 mg x 30's (Abbott Products) | |
| Duspatalin 100 mg x 50's (Abbott Products) | |
| Duspatalin 100 mg x 100's (Abbott Products) | $ 32.49 |
| Duspatalin coated tab 135 mg 50's (Abbott Products) | |
| Duspatalin 135 | |
| Duspatalin 135mg (Bulgaria) | |
| Duspatalin 200 | |
| Duspatalin 200 mg retard (Hungary) | |
| Duspatalin 200mg (Bulgaria) | |
| Duspatalin Farma 1000 (Italy) | |
| Duspatalin Pediátrico (Mexico) | |
| Duspatalin PR (Cyprus) | |
| Duspatalin Programmi Sanitari (Italy) | |
| Duspatalin Retard (Germany, Oman, Poland, Switzerland) | |
| Capsule, Prolonged Release; Oral; Mebeverine Hydrochloride 200 mg (Abbott) | |
| Tablet, Film-Coated; Oral; Mebeverine Hydrochloride 100 mg (Abbott) | |
| Duspatalin Retard 200 mg x 30's (Abbott) | |
| Duspatalin Retard cap 200 mg 30's (Abbott) | |
| Duspatalin Retard 200mg (Switzerland) | |
| Duspatalin 杜適林 (Hongkong) | |
| Duspatin (Thailand) | |
| Duspatin 135 mg x 10 x 10's (Berlin Pharm) | |
| Duspatin tab 135 mg 10 x 10's (Berlin Pharm) | |
| Duspaverin (Turkey) | |
See 252 substitutes for Duspacol 50 | |
References
- PubChem. "mebeverine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Mebeverine". http://www.drugbank.ca/drugs/DB12554 (accessed September 17, 2018).
- MeSH. "Parasympatholytics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Duspacol 50 are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Duspacol 50. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
